The expression levels of CCL2 in peripheral blood and tumor tissues were significantly lower in sh-NLRP7-treated and sh-USP10-treated mice than in control mice and higher in NLRP7-treated mice with USP10 knockdown (Fig. 6f). The gene discussed is CCL2; the disease is neoplasm.